Cargando…

Immune response in COVID-19: what is next?

The coronavirus disease 2019 (COVID-19) has been a global pandemic for more than 2 years and it still impacts our daily lifestyle and quality in unprecedented ways. A better understanding of immunity and its regulation in response to SARS-CoV-2 infection is urgently needed. Based on the current lite...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qing, Wang, Ying, Sun, Qiang, Knopf, Jasmin, Herrmann, Martin, Lin, Liangyu, Jiang, Jingting, Shao, Changshun, Li, Peishan, He, Xiaozhou, Hua, Fei, Niu, Zubiao, Ma, Chaobing, Zhu, Yichao, Ippolito, Giuseppe, Piacentini, Mauro, Estaquier, Jerome, Melino, Sonia, Weiss, Felix Daniel, Andreano, Emanuele, Latz, Eicke, Schultze, Joachim L., Rappuoli, Rino, Mantovani, Alberto, Mak, Tak Wah, Melino, Gerry, Shi, Yufang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110941/
https://www.ncbi.nlm.nih.gov/pubmed/35581387
http://dx.doi.org/10.1038/s41418-022-01015-x
_version_ 1784709215890178048
author Li, Qing
Wang, Ying
Sun, Qiang
Knopf, Jasmin
Herrmann, Martin
Lin, Liangyu
Jiang, Jingting
Shao, Changshun
Li, Peishan
He, Xiaozhou
Hua, Fei
Niu, Zubiao
Ma, Chaobing
Zhu, Yichao
Ippolito, Giuseppe
Piacentini, Mauro
Estaquier, Jerome
Melino, Sonia
Weiss, Felix Daniel
Andreano, Emanuele
Latz, Eicke
Schultze, Joachim L.
Rappuoli, Rino
Mantovani, Alberto
Mak, Tak Wah
Melino, Gerry
Shi, Yufang
author_facet Li, Qing
Wang, Ying
Sun, Qiang
Knopf, Jasmin
Herrmann, Martin
Lin, Liangyu
Jiang, Jingting
Shao, Changshun
Li, Peishan
He, Xiaozhou
Hua, Fei
Niu, Zubiao
Ma, Chaobing
Zhu, Yichao
Ippolito, Giuseppe
Piacentini, Mauro
Estaquier, Jerome
Melino, Sonia
Weiss, Felix Daniel
Andreano, Emanuele
Latz, Eicke
Schultze, Joachim L.
Rappuoli, Rino
Mantovani, Alberto
Mak, Tak Wah
Melino, Gerry
Shi, Yufang
author_sort Li, Qing
collection PubMed
description The coronavirus disease 2019 (COVID-19) has been a global pandemic for more than 2 years and it still impacts our daily lifestyle and quality in unprecedented ways. A better understanding of immunity and its regulation in response to SARS-CoV-2 infection is urgently needed. Based on the current literature, we review here the various virus mutations and the evolving disease manifestations along with the alterations of immune responses with specific focuses on the innate immune response, neutrophil extracellular traps, humoral immunity, and cellular immunity. Different types of vaccines were compared and analyzed based on their unique properties to elicit specific immunity. Various therapeutic strategies such as antibody, anti-viral medications and inflammation control were discussed. We predict that with the available and continuously emerging new technologies, more powerful vaccines and administration schedules, more effective medications and better public health measures, the COVID-19 pandemic will be under control in the near future. [Image: see text]
format Online
Article
Text
id pubmed-9110941
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-91109412022-05-17 Immune response in COVID-19: what is next? Li, Qing Wang, Ying Sun, Qiang Knopf, Jasmin Herrmann, Martin Lin, Liangyu Jiang, Jingting Shao, Changshun Li, Peishan He, Xiaozhou Hua, Fei Niu, Zubiao Ma, Chaobing Zhu, Yichao Ippolito, Giuseppe Piacentini, Mauro Estaquier, Jerome Melino, Sonia Weiss, Felix Daniel Andreano, Emanuele Latz, Eicke Schultze, Joachim L. Rappuoli, Rino Mantovani, Alberto Mak, Tak Wah Melino, Gerry Shi, Yufang Cell Death Differ Review Article The coronavirus disease 2019 (COVID-19) has been a global pandemic for more than 2 years and it still impacts our daily lifestyle and quality in unprecedented ways. A better understanding of immunity and its regulation in response to SARS-CoV-2 infection is urgently needed. Based on the current literature, we review here the various virus mutations and the evolving disease manifestations along with the alterations of immune responses with specific focuses on the innate immune response, neutrophil extracellular traps, humoral immunity, and cellular immunity. Different types of vaccines were compared and analyzed based on their unique properties to elicit specific immunity. Various therapeutic strategies such as antibody, anti-viral medications and inflammation control were discussed. We predict that with the available and continuously emerging new technologies, more powerful vaccines and administration schedules, more effective medications and better public health measures, the COVID-19 pandemic will be under control in the near future. [Image: see text] Nature Publishing Group UK 2022-05-17 2022-06 /pmc/articles/PMC9110941/ /pubmed/35581387 http://dx.doi.org/10.1038/s41418-022-01015-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review Article
Li, Qing
Wang, Ying
Sun, Qiang
Knopf, Jasmin
Herrmann, Martin
Lin, Liangyu
Jiang, Jingting
Shao, Changshun
Li, Peishan
He, Xiaozhou
Hua, Fei
Niu, Zubiao
Ma, Chaobing
Zhu, Yichao
Ippolito, Giuseppe
Piacentini, Mauro
Estaquier, Jerome
Melino, Sonia
Weiss, Felix Daniel
Andreano, Emanuele
Latz, Eicke
Schultze, Joachim L.
Rappuoli, Rino
Mantovani, Alberto
Mak, Tak Wah
Melino, Gerry
Shi, Yufang
Immune response in COVID-19: what is next?
title Immune response in COVID-19: what is next?
title_full Immune response in COVID-19: what is next?
title_fullStr Immune response in COVID-19: what is next?
title_full_unstemmed Immune response in COVID-19: what is next?
title_short Immune response in COVID-19: what is next?
title_sort immune response in covid-19: what is next?
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110941/
https://www.ncbi.nlm.nih.gov/pubmed/35581387
http://dx.doi.org/10.1038/s41418-022-01015-x
work_keys_str_mv AT liqing immuneresponseincovid19whatisnext
AT wangying immuneresponseincovid19whatisnext
AT sunqiang immuneresponseincovid19whatisnext
AT knopfjasmin immuneresponseincovid19whatisnext
AT herrmannmartin immuneresponseincovid19whatisnext
AT linliangyu immuneresponseincovid19whatisnext
AT jiangjingting immuneresponseincovid19whatisnext
AT shaochangshun immuneresponseincovid19whatisnext
AT lipeishan immuneresponseincovid19whatisnext
AT hexiaozhou immuneresponseincovid19whatisnext
AT huafei immuneresponseincovid19whatisnext
AT niuzubiao immuneresponseincovid19whatisnext
AT machaobing immuneresponseincovid19whatisnext
AT zhuyichao immuneresponseincovid19whatisnext
AT ippolitogiuseppe immuneresponseincovid19whatisnext
AT piacentinimauro immuneresponseincovid19whatisnext
AT estaquierjerome immuneresponseincovid19whatisnext
AT melinosonia immuneresponseincovid19whatisnext
AT weissfelixdaniel immuneresponseincovid19whatisnext
AT andreanoemanuele immuneresponseincovid19whatisnext
AT latzeicke immuneresponseincovid19whatisnext
AT schultzejoachiml immuneresponseincovid19whatisnext
AT rappuolirino immuneresponseincovid19whatisnext
AT mantovanialberto immuneresponseincovid19whatisnext
AT maktakwah immuneresponseincovid19whatisnext
AT melinogerry immuneresponseincovid19whatisnext
AT shiyufang immuneresponseincovid19whatisnext